Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reinders

Showing results (131-140 of 214) with videos related to

Pageof 22
Sort By:
British Journal of Clinical Pharmacology|November 21, 2022
Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantationTom C Zwart, Suzanne Bezstarosti, Federica R Achini, et al.
Cell Death & Disease|March 2, 2012
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cellsC Sanges, C Scheuermann, R P Zahedi, et al.
Stem Cells and Development|August 11, 2020
Treating Ischemically Damaged Porcine Kidneys with Human Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stromal Cells During Ex Vivo Normothermic Machine PerfusionMerel B F Pool, Jaël Vos, Marco Eijken, et al.
Journal of Medical Internet Research|September 18, 2020
Topics, Delivery Modes, and Social-Epistemological Dimensions of Web-Based Information for Patients Undergoing Renal Transplant and Living Donors During the COVID-19 Pandemic: Content AnalysisCharlotte W van Klaveren, Peter G M de Jong, Renée A Hendriks, et al.
Transplant Immunology|May 11, 2021
Single antigen testing to reduce early antibody-mediated rejection risk in female recipients of a spousal donor kidneyKoen E Groeneweg, Fréderique A van der Toorn, Dave L Roelen, et al.
British Journal of Clinical Pharmacology|March 26, 2018
A pharmacological rationale for improved everolimus dosing in oncology and transplant patientsR Ter Heine, N P van Erp, H J Guchelaar, et al.
Clinical Pharmacology and Therapeutics|August 14, 2024
Prediction of the Intra-T Lymphocyte Tacrolimus Concentration after Kidney Transplantation with Population Pharmacokinetic ModelingSuwasin Udomkarnjananun, Maaike R Schagen, Helena Volarević, et al.
JAMA Surgery|September 25, 2024
Kidney Transplant Outcome Following Donation After EuthanasiaJulia S Slagter, Hendrikus J A N Kimenai, Jacqueline van de Wetering, et al.
Clinical Pharmacology and Therapeutics|February 24, 2022
Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant RejectionDaphne M Hullegie-Peelen, Marieke van der Zwan, Marian C Clahsen-van Groningen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 1, 2020
Diabetic nephropathy alters circulating long noncoding RNA levels that normalize following simultaneous pancreas-kidney transplantationKoen E Groeneweg, Yu Wah Au, Jacques M G J Duijs, et al.
Pageof 22

Showing results (131-140 of 214) with videos related to

Sort By:
Pageof 22
British Journal of Clinical Pharmacology|November 21, 2022
Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantationTom C Zwart, Suzanne Bezstarosti, Federica R Achini, et al.
Cell Death & Disease|March 2, 2012
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cellsC Sanges, C Scheuermann, R P Zahedi, et al.
Stem Cells and Development|August 11, 2020
Treating Ischemically Damaged Porcine Kidneys with Human Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stromal Cells During Ex Vivo Normothermic Machine PerfusionMerel B F Pool, Jaël Vos, Marco Eijken, et al.
Journal of Medical Internet Research|September 18, 2020
Topics, Delivery Modes, and Social-Epistemological Dimensions of Web-Based Information for Patients Undergoing Renal Transplant and Living Donors During the COVID-19 Pandemic: Content AnalysisCharlotte W van Klaveren, Peter G M de Jong, Renée A Hendriks, et al.
Transplant Immunology|May 11, 2021
Single antigen testing to reduce early antibody-mediated rejection risk in female recipients of a spousal donor kidneyKoen E Groeneweg, Fréderique A van der Toorn, Dave L Roelen, et al.
British Journal of Clinical Pharmacology|March 26, 2018
A pharmacological rationale for improved everolimus dosing in oncology and transplant patientsR Ter Heine, N P van Erp, H J Guchelaar, et al.
Clinical Pharmacology and Therapeutics|August 14, 2024
Prediction of the Intra-T Lymphocyte Tacrolimus Concentration after Kidney Transplantation with Population Pharmacokinetic ModelingSuwasin Udomkarnjananun, Maaike R Schagen, Helena Volarević, et al.
JAMA Surgery|September 25, 2024
Kidney Transplant Outcome Following Donation After EuthanasiaJulia S Slagter, Hendrikus J A N Kimenai, Jacqueline van de Wetering, et al.
Clinical Pharmacology and Therapeutics|February 24, 2022
Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant RejectionDaphne M Hullegie-Peelen, Marieke van der Zwan, Marian C Clahsen-van Groningen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 1, 2020
Diabetic nephropathy alters circulating long noncoding RNA levels that normalize following simultaneous pancreas-kidney transplantationKoen E Groeneweg, Yu Wah Au, Jacques M G J Duijs, et al.
Pageof 22